Literature DB >> 23105768

Effect of anti-epileptic drugs in pregnancy and teratogenesis.

Sowbhagya Lakshmi1, Kulkarni Sunanda.   

Abstract

Epilepsy raises special concern in women during pregnancy. Antiepileptic drugs are known to induce major and minor malformations in the foetus. Aim of the study was to find an association between maternal serum alpha fetoprotein levels, foetal abnormalities and antiepileptic drugs mediated teratogenicity. Maternal serum alpha feto protein levels, kidney and liver function tests in age matched normal pregnant women and seizure free epileptic pregnant women during 12-14 weeks of gestation were estimated. Cases were subjected to ultrasonography at 11(th)-14(th) week of pregnancy and again at 20(th) week of pregnancy. maternal serum alfa feto protein was assayed by a specific Electro Chemiluminescence Immuno Assay test. There was no significant difference in kidney and liver function tests in cases as compared to controls. There were elevated levels of alpha feto protein in cases as compared to controls but this was not statistically significant. No anomalies were detected in ultrasound reports. Most women had normal full term delivery with healthy children but of low birth weight. No correlation was seen between maternal serum alfa feto protein levels and antiepileptic drug leading to teratogenesis.

Entities:  

Keywords:  Alpha feto proteins; Antiepileptic drugs; Chemiluminescence; Teratogenic effects

Year:  2008        PMID: 23105768      PMCID: PMC3453438          DOI: 10.1007/s12291-008-0060-0

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  32 in total

1.  Serum alpha feto-protein screening in high risk pregnancies.

Authors:  M Kaur; I C Verma
Journal:  Indian J Pediatr       Date:  1995 Jan-Feb       Impact factor: 1.967

Review 2.  Teratogenicity of sodium valproate.

Authors:  Rachel Alsdorf; Diego F Wyszynski
Journal:  Expert Opin Drug Saf       Date:  2005-03       Impact factor: 4.250

3.  Neuropsychological effects of exposure to anticonvulsant medication in utero.

Authors:  J Vinten; N Adab; U Kini; J Gorry; J Gregg; G A Baker
Journal:  Neurology       Date:  2005-03-22       Impact factor: 9.910

Review 4.  Management of epilepsy in women.

Authors:  M D O'Brien; S K Gilmour-White
Journal:  Postgrad Med J       Date:  2005-05       Impact factor: 2.401

Review 5.  Birth defects after prenatal exposure to antiepileptic drugs.

Authors:  Emilio Perucca
Journal:  Lancet Neurol       Date:  2005-11       Impact factor: 44.182

Review 6.  Yolk sac tumors and alpha-fetoprotein in first year of life.

Authors:  J A Brewer; E S Tank
Journal:  Urology       Date:  1993-07       Impact factor: 2.649

7.  Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects.

Authors:  G M Shaw; D Schaffer; E M Velie; K Morland; J A Harris
Journal:  Epidemiology       Date:  1995-05       Impact factor: 4.822

Review 8.  Pregnancy and epilepsy.

Authors:  M S Yerby
Journal:  Epilepsia       Date:  1991       Impact factor: 5.864

9.  Oxcarbazepine in pregnancy: clinical experience in Argentina.

Authors:  Ricardo Meischenguiser; Carlos H D'Giano; Stella M Ferraro
Journal:  Epilepsy Behav       Date:  2004-04       Impact factor: 2.937

10.  Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study.

Authors:  K Wide; B Winbladh; B Källén
Journal:  Acta Paediatr       Date:  2004-02       Impact factor: 2.299

View more
  1 in total

1.  Reduction in mortality and teratogenicity following simultaneous administration of folic acid and vitamin E with antiepileptic, antihypertensive and anti-allergic drugs.

Authors:  Shahana Wahid; Rafeeq Alam Khan; Zeeshan Feroz
Journal:  J Pharm Bioallied Sci       Date:  2014-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.